Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Nov 15, 2019
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (right to buy)
2019-11-13+7,437→ 7,437 totalExercise: $2.43Exp: 2029-11-12→ Common Stock (7,437 underlying)
Footnotes (1)
- [F1]The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date.